2020
In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC*-Au-SCSNMe(2) and NHC*-Au-S-GLUC against advanced prostate cancer PC3.
Walther, W. and Althagafi, D. and Curran, D. and O'Beirne, C. and Mc Carthy, C. and Ott, I. and Basu, U. and Büttner, B. and Sterner-Kock, A. and Müller-Bunz, H. and Sánchez-Sanz, G. and Zhu, X. and Tacke, M.
Anti-Cancer Drugs 31
(7): 672-683.
August 2020
2012
Sorafenib, but not sunitinib, induces regulatory T cells in the peripheral blood of patients with metastatic renal cell carcinoma.
Floercken, A. and Takvorian, A. and Van Lessen, A. and Singh, A. and Hopfenmueller, W. and Doerken, B. and Pezzutto, A. and Westermann, J.
Anti-Cancer Drugs 23
(3): 298-302.
March 2012
2008
HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells.
Wegener, D. and Deubzer, H.E. and Oehme, I. and Milde, T. and Hildmann, C. and Schwienhorst, A. and Witt, O.
Anti-Cancer Drugs 19
(9): 849-857.
October 2008
2006
Anti-tumor activity of Titanocene Y in xenografted Caki-1 tumors in mice.
Fichtner, I. and Pampillon, C. and Sweeney, N.J. and Strohfeldt, K. and Tacke, M.
Anti-Cancer Drugs 17
(3): 333-336.
March 2006
2004
Reduction of tamoxifen resistance in human breast carcinomas by tamoxifen-containing liposomes in vivo.
Zeisig, R. and Rueckerl, D. and Fichtner, I.
Anti-Cancer Drugs 15
(7): 707-714.
1 August 2004
2003
Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II study.
Thuss-Patience, P.C. and von Minckwitz, G. and Kretzschmar, A. and Loibl, S. and Schaller, G. and Doerken, B. and Reichardt, P.
Anti-Cancer Drugs 14
(7): 549-553.
1 August 2003
1997
Effects of amifostine (WR-2721, ethyol) on tumor growth and pharmacology of cytotoxic drugs in human xenotransplanted neuroblastomas.
Fichtner, I. and Lemm, M. and Becker, M. and Berthold, F.
Anti-Cancer Drugs 8
: 174-181.
1 January 1997
1993
Antineoplastic activity in vitro of free and liposomal alkylphosphocholines.
Zeisig, R. and Jungmann, S. and Arndt, D. and Schuett, A. and Nissen, E.
Anti-Cancer Drugs 4
: 57-64.
1 January 1993
1991
Pharmacokinetic behavior of 57CO-Bleomycin liposomes in mice: comparison with the unencapsulated substance.
Fichtner, I. and Arndt, D. and Reszka, R. and Gens, J.
Anti-Cancer Drugs 2
: 555-563.
1 January 1991
Antitumor effects of alkylphosphocholines in different murine tumor models, use of liposomal preparations.
Zeisig, R. and Fichtner, I. and Arndt, D. and Jungmann, S.
Anti-Cancer Drugs 2
: 411-417.
1 January 1991
This list was generated on Fri Mar 29 02:34:27 2024 CET.